Tevogen Bio Holdings Inc. announced a 1-for-50 reverse stock split effective March 6, 2026, following stockholder approval on February 19, 2026, reducing the total shares from 202,416,556. This adjustment will maintain stockholders' ownership percentages, with fractional shares paid out in cash based on the pre-split closing price.